These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10810242)

  • 1. Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray.
    Chiou LC
    J Biomed Sci; 2000; 7(3):232-40. PubMed ID: 10810242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
    Chiou LC
    Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
    Chiou LC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC; Fan SH; Guerrini R; Caló G
    Neuropharmacology; 2002 Feb; 42(2):246-52. PubMed ID: 11804621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
    Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
    Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
    Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
    Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin-induced outward current in substantia gelatinosa neurones of the adult rat spinal cord.
    Luo C; Kumamoto E; Furue H; Yoshimura M
    Neuroscience; 2001; 108(2):323-30. PubMed ID: 11734364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE; Farrier DE; Wilson SG; Mogil JS
    Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurons in vitro.
    Shirasaka T; Miyahara S; Takasaki M; Kannan H
    Brain Res; 2001 Jan; 890(1):147-53. PubMed ID: 11164777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.
    Vaughan CW; Connor M; Jennings EA; Marinelli S; Allen RG; Christie MJ
    J Physiol; 2001 Aug; 534(Pt 3):849-59. PubMed ID: 11483714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphanin FQ-induced outward current in rat hippocampus.
    Amano T; Matsubayashi H; Tamura Y; Takahashi T
    Brain Res; 2000 Jan; 853(2):269-74. PubMed ID: 10640623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro.
    Connor M; Vaughan CW; Jennings EA; Allen RG; Christie MJ
    Br J Pharmacol; 1999 Dec; 128(8):1779-87. PubMed ID: 10588934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
    Schlicker E; Werthwein S; Kathmann M; Bauer U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
    Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
    Flau K; Redmer A; Liedtke S; Kathmann M; Schlicker E
    Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY; Trapella C; Chiou LC
    Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.